Tight junction proteins in glial tumors development and progression.

in Frontiers in cellular neuroscience by Jakub Moskal, Slawomir Michalak

TLDR

  • The study explores the role of tight junctions in glioma formation and progression, highlighting dysregulation and dislocation of tight junction proteins, which affects chemotherapeutic drug delivery and peritumoral edema development.

Abstract

Tight junctions form a paracellular barrier in epithelial and endothelial cells, and they regulate the diffusion of fluids, molecules, and the penetration of cells across tissue compartments. Tight junctions are composed of a group of integral membrane proteins, which include the claudin family, tight junction-associated Marvel protein family, junctional adhesion molecule family, and proteins that anchor the cytoskeleton, such asproteins and the cingulin family. Several factors, such as neurotransmitters or cytokines, and processes like ischemia/hypoxia, inflammation, tumorigenesis, phosphorylation/dephosphorylation, ubiquitination, and palmitoylation, regulate tight junction proteins. Claudins are involved in tumorigenesis processes that lead to glioma formation. In gliomas, there is a noticeable dysregulation of claudins, occludin, andabundance, and their dislocation has been observed. The weakening of intercellular adhesion and cell detachment is responsible for glioma infiltration into surrounding tissues. Furthermore, the paracellular permeability of the blood-brain barrier, formed with the involvement of tight junction proteins, influences the development of peritumoral edema - and, simultaneously, the rate of drug delivery to the glial tumor. Understanding the junctional and paracellular environments in brain tumors is crucial to predicting glial tumor progression and the feasibility of chemotherapeutic drug delivery. This knowledge may also illuminate differences between high and low-grade gliomas.

Overview

  • The study focuses on tight junctions, which form a paracellular barrier in epithelial and endothelial cells, regulating fluid diffusion, molecule transport, and cell penetration across tissue compartments.
  • The study explores the composition and regulation of tight junction proteins, including the claudin family, tight junction-associated Marvel protein family, junctional adhesion molecule family, and cytoskeleton-anchoring proteins.
  • The primary objective is to understand the role of tight junctions in glioma formation and progression, as well as the potential impact on chemotherapeutic drug delivery and peritumoral edema development.

Comparative Analysis & Findings

  • The study highlights dysregulation and dislocation of claudin, occludin, and other tight junction proteins in gliomas, leading to intercellular adhesion weakening and cell detachment.
  • The research shows that the paracellular permeability of the blood-brain barrier, influenced by tight junction proteins, affects peritumoral edema development and chemotherapeutic drug delivery to gliomas.
  • The study suggests that understanding the junctional and paracellular environments in brain tumors is crucial for predicting glioma progression and chemotherapeutic drug delivery feasibility.

Implications and Future Directions

  • The findings have significant implications for understanding glioma development and progression, as well as the development of effective chemotherapeutic strategies.
  • Future research directions include exploring differences between high and low-grade gliomas, investigating the role of tight junctions in other types of brain tumors, and developing targeted therapies to modulate tight junction protein function.
  • Further studies should aim to elucidate the cellular and molecular mechanisms underlying tight junction protein dysregulation and dislocation in gliomas, as well as the effects of chemotherapy and radiation on tight junctions.